FTC sues big pharmacy profit supervisors over insulin selling prices The agency introduced action in opposition to Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the list cost of existence-conserving insulin medications. Insurers will carry on vertically integrating to help keep additional income https://busch-light-peach-nutriti27372.blogkoo.com/details-fiction-and-healthcare-news-50280238